EconPapers    
Economics at your fingertips  
 

Details about Iain M. Cockburn

E-mail:
Homepage:http://people.bu.edu/cockburn
Workplace:National Bureau of Economic Research (NBER), (more information at EDIRC)
Department of Strategy and Innovation, Questrom School of Business, Boston University, (more information at EDIRC)

Access statistics for papers by Iain M. Cockburn.

Last updated 2017-08-31. Update your information in the RePEc Author Service.

Short-id: pco166


Jump to Journal Articles Chapters

Working Papers

2016

  1. Patents and the global diffusion of new drugs
    LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library Downloads View citations (2)
    Also in CEPR Discussion Papers, C.E.P.R. Discussion Papers (2014) Downloads View citations (2)
    CEP Discussion Papers, Centre for Economic Performance, LSE (2014) Downloads View citations (2)
    LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library (2014) Downloads View citations (2)
    NBER Working Papers, National Bureau of Economic Research, Inc (2014) Downloads View citations (2)

    See also Journal Article in American Economic Review (2016)

2013

  1. Deals Not Done: Sources of Failure in the Market for Ideas
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (3)
    See also Journal Article in Strategic Management Journal (2015)
  2. Price Indexes for Clinical Trial Research: A Feasibility Study
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
  3. The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (2)
    See also Chapter (2013)
  4. Why are some regions more innovative than others? The role of firm size diversity
    CEPR Discussion Papers, C.E.P.R. Discussion Papers Downloads
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (2012) Downloads View citations (16)

2009

  1. Not Invented Here? Innovation in Company Towns
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
    See also Journal Article in Journal of Urban Economics (2010)
    Chapter (2010)
  2. Patent thickets, licensing and innovative performance
    ZEW Discussion Papers, ZEW - Zentrum für Europäische Wirtschaftsforschung / Center for European Economic Research Downloads View citations (2)
    Also in ZEW Discussion Papers, ZEW - Zentrum für Europäische Wirtschaftsforschung / Center for European Economic Research (2008) Downloads View citations (2)

    See also Journal Article in Industrial and Corporate Change (2010)

2007

  1. Patents and the Survival of Internet-related IPOs
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (29)
    See also Journal Article in Research Policy (2010)
  2. Patents, Thickets, and the Financing of Early-Stage Firms: Evidence from the Software Industry
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (8)
    See also Journal Article in Journal of Economics & Management Strategy (2009)
    Chapter (2007)

2006

  1. Entry and Patenting in the Software Industry
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (6)
    See also Journal Article in Management Science (2011)
  2. Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (6)
    See also Journal Article in Annals of Economics and Statistics (2005)

2004

  1. Faster, Smaller, Cheaper: An Hedonic Price Analysis of PDAs
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (3)
    See also Journal Article in Applied Economics (2008)

2003

  1. Gone But Not Forgotten: Labor Flows, Knowledge Spillovers, and Enduring Social Capital
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (50)

2002

  1. Are All Patent Examiners Equal? The Impact of Examiner Characteristics
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (27)
  2. University Research, Industrial R&D, and the Anchor Tenant Hypothesis
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (13)

2000

  1. Do Patents Matter?: Empirical Evidence after GATT
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (20)

1999

  1. Balancing Incentives: The Tension Between Basic and Applied Research
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (31)
  2. The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (17)

1998

  1. Hedonic Analysis of Arthritis Drugs
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (12)
    See also Chapter (2001)

1997

  1. Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (3)
    See also Journal Article in Forum for Health Economics & Policy (1998)
    Chapter (1998)
  2. Public-Private Interaction and the Productivity of Pharmaceutical Research
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (25)

1996

  1. Characteristics of Demand for Pharmaceutical Products: an Examination of four Cephalosporins
    Working papers, Massachusetts Institute of Technology (MIT), Department of Economics View citations (18)
    See also Journal Article in RAND Journal of Economics (1997)

1994

  1. Measuring competence?: exploring firm effects in pharmaceutical research
    Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management Downloads View citations (252)
  2. Racing to invest?: the dynamics of competition in ethical drug discovery
    Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management Downloads View citations (42)
    See also Journal Article in Journal of Economics & Management Strategy (1994)

1993

  1. Generics and New Goods in Pharmaceutical Price Indexes
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (4)
    See also Journal Article in American Economic Review (1994)
  2. Racing or spilling?: the determinants of research productivity in ethical drug discovery
    Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management Downloads View citations (2)
  3. Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (7)
  4. Scale, scope and spillovers: the determinants of research productivity in ethical drug discovery
    Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management Downloads View citations (4)

1992

  1. Market Conditions and Retirement of Physical Capital: Evidence fron Oil Tankers
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (4)

1987

  1. Industry Effects and Appropriability Measures in the Stock Markets Valuation of R&D and Patents
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (13)
    See also Journal Article in American Economic Review (1988)

Undated

  1. A Mixed Poisson Regression Model for Analysis of Patent Data
    Computing in Economics and Finance 1996, Society for Computational Economics
  2. Scale, Scope and Spillovers: The Determinants of Research Productivity in Drug Discovery
    Working Papers, Department of Economics, University of Lancaster View citations (50)
    See also Journal Article in RAND Journal of Economics (1996)

Journal Articles

2016

  1. Patents and the Global Diffusion of New Drugs
    American Economic Review, 2016, 106, (1), 136-64 Downloads View citations (2)
    See also Working Paper (2016)

2015

  1. Deals not done: Sources of failure in the market for ideas
    Strategic Management Journal, 2015, 36, (7), 976-986 Downloads View citations (4)
    See also Working Paper (2013)

2014

  1. Why are some regions more innovative than others? The role of small firms in the presence of large labs
    Journal of Urban Economics, 2014, 81, (C), 149-165 Downloads View citations (13)

2013

  1. Access to intellectual property for innovation: Evidence on problems and coping strategies from German firms
    Research Policy, 2013, 42, (2), 529-541 Downloads

2012

  1. Information Technology and Intangible Output: The Impact of IT Investment on Innovation Productivity
    Information Systems Research, 2012, 23, (1), 42-59 Downloads View citations (3)

2011

  1. Diffusion of New Drugs in the Post-TRIPS Era
    International Journal of the Economics of Business, 2011, 18, (2), 203-224 Downloads View citations (2)
  2. Entry and Patenting in the Software Industry
    Management Science, 2011, 57, (5), 915-933 Downloads View citations (30)
    See also Working Paper (2006)

2010

  1. Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy
    Capitalism and Society, 2010, 5, (1), 1-50 Downloads View citations (1)
  2. Not Invented Here? Innovation in company towns
    Journal of Urban Economics, 2010, 67, (1), 78-89 Downloads View citations (28)
    See also Chapter (2010)
    Working Paper (2009)
  3. Patent thickets, licensing and innovative performance
    Industrial and Corporate Change, 2010, 19, (3), 899-925 Downloads View citations (22)
    See also Working Paper (2009)
  4. Patents and the survival of Internet-related IPOs
    Research Policy, 2010, 39, (2), 214-228 Downloads View citations (25)
    See also Working Paper (2007)
  5. The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions
    Innovation Policy and the Economy, 2010, 10, (1), 129 - 157 Downloads
    See also Chapter (2010)

2009

  1. Patents, Thickets and the Financing of Early-Stage Firms: Evidence from the Software Industry
    Journal of Economics & Management Strategy, 2009, 18, (3), 729-773 Downloads View citations (43)
    See also Working Paper (2007)
    Chapter (2007)

2008

  1. Faster, smaller, cheaper: an hedonic price analysis of PDAs
    Applied Economics, 2008, 40, (22), 2839-2856 Downloads View citations (9)
    See also Working Paper (2004)

2006

  1. The Impact of Incremental Innovation in Biopharmaceuticals
    PharmacoEconomics, 2006, 24, (2), 69-86 Downloads View citations (1)

2005

  1. Public & Private Spillovers: Location and the Productivity of Pharmaceutical Research
    Annals of Economics and Statistics, 2005, (79-80), 165-188 Downloads View citations (2)
    See also Working Paper (2006)

2003

  1. The anchor tenant hypothesis: exploring the role of large, local, R&D-intensive firms in regional innovation systems
    International Journal of Industrial Organization, 2003, 21, (9), 1227-1253 Downloads View citations (70)

2001

  1. New Pills for Poor People? Empirical Evidence after GATT
    World Development, 2001, 29, (2), 265-289 Downloads View citations (39)
  2. Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research
    Journal of Health Economics, 2001, 20, (6), 1033-1057 Downloads View citations (40)

1998

  1. Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery
    Journal of Industrial Economics, 1998, 46, (2), 157-82 Downloads View citations (251)
  2. Analysis of Patent Data--A Mixed-Poisson-Regression-Model Approach
    Journal of Business & Economic Statistics, 1998, 16, (1), 27-41 View citations (38)
  3. Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs
    Forum for Health Economics & Policy, 1998, 1, (1), 1-45 Downloads View citations (2)
    See also Chapter (1998)
    Working Paper (1997)

1997

  1. Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins
    RAND Journal of Economics, 1997, 28, (3), 426-446 Downloads View citations (48)
    See also Working Paper (1996)
  2. Generics and New Goods in Pharmaceutical Price Indexes: Reply
    American Economic Review, 1997, 87, (4), 768 Downloads

1996

  1. Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery
    RAND Journal of Economics, 1996, 27, (1), 32-59 Downloads View citations (228)
    See also Working Paper

1995

  1. Opportunity costs and entrepreneurial activity
    Journal of Business Venturing, 1995, 10, (2), 95-106 Downloads View citations (46)

1994

  1. Generics and New Goods in Pharmaceutical Price Indexes
    American Economic Review, 1994, 84, (5), 1213-32 Downloads View citations (46)
    See also Working Paper (1993)
  2. Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery
    Journal of Economics & Management Strategy, 1994, 3, (3), 481-519 View citations (56)
    See also Working Paper (1994)

1988

  1. Industry Effects and Appropriability Measures in the Stock Market's Valuation of R&D and Patents
    American Economic Review, 1988, 78, (2), 419-23 Downloads View citations (127)
    See also Working Paper (1987)

Chapters

2017

  1. The Impact of Artificial Intelligence on Innovation
    A chapter in Economics of Artificial Intelligence, 2017 Downloads

2013

  1. The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales following Loss of Exclusivity
    A chapter in Measuring and Modeling Health Care Costs, 2013 Downloads View citations (2)
    See also Working Paper (2013)

2011

  1. Comment on "The Confederacy of Heterogeneous Software Organizations and Heterogeneous Developers: Field Experimental Evidence on Sorting and Worker Effort"
    A chapter in The Rate and Direction of Inventive Activity Revisited, 2011, pp 502-505 Downloads
  2. Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Energy R&D
    A chapter in Accelerating Energy Innovation: Insights from Multiple Sectors, 2011, pp 113-157 Downloads

2010

  1. Not Invented Here? Innovation in Company Towns
    A chapter in Cities and Entrepreneurship, 2010 View citations (22)
    See also Journal Article in Journal of Urban Economics (2010)
    Working Paper (2009)
  2. Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research
    A chapter in Contributions in Memory of Zvi Griliches, 2010, pp 165-188 View citations (15)
  3. The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions
    A chapter in Innovation Policy and the Economy, Volume 10, 2010, pp 129-157 Downloads
    See also Journal Article in Innovation Policy and the Economy (2010)

2009

  1. Comments on Nathan Rosenberg’s ‘Critical Episodes in the Progress of Medical Innovation’
    Chapter 11 in The New Economics of Technology Policy, 2009 Downloads

2007

  1. Is the Pharmaceutical Industry in a Productivity Crisis?
    A chapter in Innovation Policy and the Economy, Volume 7, 2007, pp 1-32 Downloads View citations (4)
  2. Patents, Thickets and the Financing of Eastly-Stage Firms; Evidence from the Software Industry
    A chapter in Entrepreneurship: Strategy and Structure, 2007
    See also Journal Article in Journal of Economics & Management Strategy (2009)
    Working Paper (2007)

2001

  1. Hedonic Analysis of Arthritis Drugs
    A chapter in Medical Care Output and Productivity, 2001, pp 439-462 Downloads View citations (5)
    See also Working Paper (1998)
  2. Publicly Funded Science and the Productivity of the Pharmaceutical Industry
    A chapter in Innovation Policy and the Economy, Volume 1, 2001, pp 1-34 Downloads View citations (14)

1998

  1. Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs
    A chapter in Frontiers in Health Policy Research, Volume 1, 1998, pp 33-76 Downloads View citations (2)
    See also Working Paper (1997)
    Journal Article in Forum for Health Economics & Policy (1998)
 
Page updated 2017-12-05